Forecasts data is unavailable for this security.
Consensus recommendation
- 19-Oct-23
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
- 26-Sep-24
Select bar for recommendation details.
Recommendations | 26-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 0 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast
The 2 analysts offering 12 month price targets for Shield Therapeutics PLC have a median target of 16.75, with a high estimate of 30.00 and a low estimate of 3.50. The median estimate represents a 248.96% increase from the last price of 4.80.
High | 525.0% | 30.00 |
Med | 249.0% | 16.75 |
Low | -27.1% | 3.50 |
Earnings history & estimates
Average growth rate | -59.12% |
More ▼
Revenue history & estimates
Average growth rate | +397.24% |
More ▼